Petersen, Inge
,
Bhana, Arvin
Folb, Naomi http://orcid.org/0000-0002-2667-0956
Thornicroft, Graham
Zani, Babalwa
Selohilwe, One
Petrus, Ruwayda
Mntambo, Ntokozo
Georgeu-Pepper, Daniella
Kathree, Tasneem
Lund, Crick
Lombard, Carl
Bachmann, Max
Gaziano, Thomas
Levitt, Naomi
Fairall, Lara
Funding for this research was provided by:
Department for International Development (HRPC10)
Article History
Received: 5 January 2017
Accepted: 8 September 2017
First Online: 22 March 2018
Ethics approval and consent to participate
: Ethical approval for the study was obtained from the University of KwaZulu-Natal’s Biomedical Research Ethics Committee (BREC) (reference BFC049/15); the University of Cape Town’s Faculty of Health Sciences Human Research Ethics Committee (reference HREC: 412/2011); as well as the Department of Health in the North West Province of South Africa. All amendments to the protocol are approved by BREC at the University of KwaZulu-Natal and amended on the trial registries. Given that randomisation of the clinics to the intervention and control condition was carried out prior to data collection, informed consent was only obtained from patients to participate in individual data collection and not for randomisation. Informed consent procedures have been described in detail in the recruitment section. Informed consent required that patients understood that their participation was voluntary and that they could withdraw at any stage; were required to sit for three interviews (baseline, 6 months and 12 months), and permit access to their patient records for research purposes.
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.